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Abstract: Although inherited GJA1 (encoding Cx43) gene mutations most often lead to oculodentodigital dysplasia and related disorders, four variants have been linked to erythrokeratodermia variabilis
et progressiva (EKVP), a skin disorder characterized by erythematous and hyperkeratotic lesions.
While two autosomal-dominant EKVP-linked GJA1 mutations have been shown to lead to augmented
hemichannels, the consequence(s) of keratinocytes harboring a de novo P283L variant alone or in
combination with a de novo T290N variant remain unknown. Interestingly, these variants reside
within or adjacent to a carboxy terminus polypeptide motif that has been shown to be important
in regulating the internalization and degradation of Cx43. Cx43-rich rat epidermal keratinocytes
(REKs) or Cx43-ablated REKs engineered to express fluorescent protein-tagged P283L and/or T290N
variants formed prototypical gap junctions at cell–cell interfaces similar to wildtype Cx43. Dye
coupling and dye uptake studies further revealed that each variant or a combination of both variants
formed functional gap junction channels, with no evidence of augmented hemichannel function or
induction of cell death. Tracking the fate of EKVP-associated variants in the presence of the protein
secretion blocker brefeldin A, or an inhibitor of protein synthesis cycloheximide, revealed that P283L
or the combination of P283L and T290N variants either significantly extended Cx43 residency on the
cell surface of keratinocytes or delayed its degradation. However, caution is needed in concluding
that this modest change in the Cx43 life cycle is sufficient to cause EKVP, or whether an additional
underlying mechanism or another unidentified gene mutation is contributing to the pathogenesis
found in patients. This question will be resolved if further patients are identified where whole exome
sequencing reveals a Cx43 P283L variant alone or, in combination with a T290N variant, co-segregates
with EKVP across several family generations.
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1. Introduction
Connexins (Cx) are a family of hemichannel and intercellular gap junction channelforming proteins that enable cells to communicate with the extracellular milieu and adjoined cells, respectively. Gap junction channel transfer of ions and small molecules of up
to 1 kDa, termed gap junctional intercellular communication (GJIC), occurs in virtually
all cell types found in the body, including keratinocytes, and is required for normal tissue
physiology and homeostasis [1]. Consequently, most cells express multiple members of the
connexin family that often intermix to form complex channel configurations with varying
permeability and gating properties [1,2].
Interestingly, as keratinocytes of the human epidermis progress through a terminal
differentiation program called keratinization, they modulate the expression of at least eight
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connexin isoforms, namely Cx26, Cx30, Cx30.3, Cx31, Cx32, Cx40, Cx43, and Cx45 [3–6].
In this context, we refer to them as ‘keratinocyte connexins’. Mutations in the genes that
encode five of these keratinocyte connexins are clinically linked to multiple cutaneous disorders with varying degrees of severity [7]. One of these disorders is erythrokeratodermia
variabilis et progressiva (EKVP), a rare hereditary skin condition characterized by distinct
and overlapping erythema and hyperkeratosis that are usually present at birth or develop
during infancy, and worsen with age [8]. While these lesions are not life-threatening,
they cause substantial morbidity due to pain and irritation. EKVP is genetically heterogenous with linkages to seven genes that include three connexin-encoding genes: GJB3
(Cx31) [9–13], GJB4 (Cx30.3) [4,14–16], and GJA1 (Cx43) [17,18].
There are ~100 mutations/variants in GJA1 identified to date that are associated with
at least six disorders [19]. The vast majority of GJA1 mutations cause oculodentodigital
dysplasia (ODDD), a disorder that commonly presents with craniofacial abnormalities, digit
fusion, and developmental defects of the eyes and teeth [20]. On rare occasions, ODDD
presents with a skin phenotype in the form of palmoplantar keratoderma (PPK) [21,22].
In 2015, the first two GJA1 mutations (p.A44V and p.E227D) were linked to EKVP [17].
Affected individuals with either mutation had normal skin at birth that progressed to PPK,
hyperkeratosis, and transient figurate erythema at sites of friction [17]. When expressed in
HeLa cells, the Cx43 mutants assembled into prototypical gap junction plaques with normal
gap junction channel properties, but also formed augmented hemichannels when expressed
in Xenopus oocytes [23]. These findings align well with hyperactive or leaky hemichannels
underpinning a number of connexin-based inherited skin pathologies [19,23–25].
Recently, two novel de novo autosomal dominant missense variants in GJA1 (p.P283L
and p.T290N) were identified in two unrelated Chinese patients with EKVP [18]. In both
cases, these variants were not detected in unaffected family members and 100 unrelated
controls, and no variants were identified in GJB3 or GJB4 [18], although other genes linked
to EKVP were not investigated [26–30]. Notably, this study reported the first case of EKVP
associated with a GJA1 double variant (p.P283L and p.T290N) being found in the same
patient, though it is unclear if both variants occurred on the same or different alleles [18].
The patient harboring the P283L variant developed erythema on the hands and feet [18].
In contrast, the patient with both P283L and T290N variants had more severe disease,
with widespread erythematous and hyperkeratotic lesions on the face, neck, limbs and
inguinal region with progressive PPK [18]. Low resolution immunofluorescent analysis of
skin biopsies suggested that these variants, along with endogenous Cx43 encoded by the
unaffected allele, may be intracellularly retained [18], although this was not entirely clear.
Structurally, the p.P283L and p.T290N variants occur within a carboxy terminus
motif of Cx43 that is the binding site for several members of the Cx43 interactome [31].
Notably, the p.P283L variant occurs within the binding sequences for c-Src, phosphatase
and tensin homolog (PTEN), C-terminal c-Src kinase (Csk), and the E3 ubiquitin ligase
NEDD4 [31–36]. A neighboring Y286A substitution increased the half-life of Cx43 from
2 h to 6 h, identifying the tyrosine-based sorting signal as important for the clearing of
Cx43 from the cell surface [36]. Prior to being identified as an EKVP-associated variant, the
P283L amino acid substitution was shown to cause a modest increase in the steady-state
levels when expressed in SKHep1 cells compared to wild-type Cx43 [36]. Due to the steric
properties of proline residues, the P283L amino acid substitution may have altered the
accessibility and functionality of proximal Cx43 binding sequences. Interestingly, the P283
site occurs in close proximity to the binding sites of Hsc70 and the µ2 subunit of the AP-2
adapter complex, which have been reported to be involved in the turnover of Cx43 [36–38].
Two MAPK phosphorylation sites that regulate NEDD4 binding are also found upstream
at residues S279 and S282 [31,32,36,39]. Thus, we speculated that the EKVP patient that
harbors both the P283L/T290N variants could have additive effects possibly explaining the
apparently more severe phenotype [18].
In the current study, we examined the cellular distribution, trafficking, stability, and
functional status of the P283L and T290N variants individually and in combination. To
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avoid a reliance on connexin-deficient reference cells from tissue unrelated to the skin,
we employed spontaneously immortalized rat epidermal keratinocytes (REKs) that retain
the capacity to fully differentiate into organotypic epidermis [40,41]. In some cases, REKs
were used that were CRISPR/Cas9 engineered to ablate Cx43 expression, to allow for the
functional status of the variants to be assessed in keratinocytes in the absence of endogenous
Cx43 [40].
2. Methods
2.1. Cell Culture, DNA Constructs, and Transfections
Wildtype rat epidermal keratinocytes (REKs), Cx43-ablated REKs, and HeLa cells
were grown in Dulbecco’s Modified Eagle’s Medium (DMEM, ThermoFisher, Burlington,
ON, Canada, Cat# 11960) supplemented with 2 mM glutamine, 10% fetal bovine serum,
and 100 U/mL penicillin and streptomycin. Cells were cultured at 37 ◦ C and 5% CO2 and
subcultured once they reached 70–80% confluency.
The generation of plasmids encoding P283L, T290N, and P283L/T290N (both variants
engineered on the same plasmid) within human Cx43 tagged to moxGFP was outsourced to
NorClone Biotech Labs (London, ON, Canada) for site-directed engineering and sequence
confirmation. For transfections, cultured HeLa cells, REKs, or REKs with endogenously
knocked-out Cx43 (Cx43–KO REKs) were transiently transfected with 1 µg DNA using
Lipofectamine 3000 (ThermoFisher, Cat# L3000015) as per the manufacturer’s instructions.
To further model the compound heterozygous state, given the ambiguity as to whether
both variants were found on the same or different alleles, cells were also transiently cotransfected as described above, with 0.5 µg of each plasmid encoding P283L or T290N
(denoted as P283L + T290N).
2.2. Immunolabeling and Microscopy
Transfected REKs or Cx43-ablated REKs plated on glass coverslips were fixed in ice
cold 80% methanol/20% acetone solution for 15 min at 4 ◦ C and subsequently blocked with
2% bovine serum albumin (BSA; MilliporeSigma, Oakville, ON, Canada, Cat# A2153) for
30 min at room temperature. Subsequently, cells were washed and incubated for one hour
at room temperature in primary antibody solutions consisting of either mouse monoclonal
anti-protein disulfide isomerase (PDI; Enzo Life Science, Burlington, ON, Canada, Cat#
ADI-SPA-891F), mouse monoclonal anti-GM130 (BD Transduction Laboratories, San Jose,
CA, USA, Cat# 610822) (both diluted 1:200), or rabbit polyclonal anti-Rab7 (Santa Cruz
Biotechnology, Dallas, TX, USA, Cat# 376362) (1:100) to demarcate the ER, Golgi apparatus,
and endosomes, respectively. In some cases, cells were incubated, as described above, with
rabbit polyclonal anti-Cx43 (MilliporeSigma, Cat# C6219) (1:200) to stain for endogenous
Cx43. Cells were subsequently washed and incubated in Alexa Fluor 555-conjugated goat
anti-mouse IgG (ThermoFisher, Cat# A32727) (1:800) or Alexa Fluor 555-conjugated goat
anti-rabbit IgG (ThermoFisher, Cat# A32732) (1:800) secondary antibodies for 1 h. All coverslips were washed and counterstained with Hoechst 33342 (ThermoFisher, Cat# H3570)
(1:1000) to demarcate the nuclei and mounted onto microscope slides using Airvol mounting medium. Confocal images were captured on a Zeiss LSM800 confocal microscope.
To assess the ability of each variant to assemble into gap junctions, a third-party
investigator that was blinded to the treatment was used to quantitate the number of gap
junction plaques at cellular interfaces of apposed transfected cells. A gap junction plaque
was defined as a linear punctate green fluorescence signal of greater than 0.2 µm situated at
a cell–cell interface between two transfected cells. A total of five independent transfections
were performed, where approximately 10–30 cell pairs were quantified.
2.3. Fluorescence Recovery after Photobleaching
Cx43-ablated REKs were seeded into 35-mm glass bottom dishes (VWR, Mississauga,
ON, Canada, Cat# 10810-056) and incubated for 24 h at 37 ◦ C and 5% CO2 . Each dish was
loaded with CellTrace™ Calcein Red-Orange, AM (ThermoFisher, Cat# C34851) (5 µg/mL)
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for 10 min at 37 ◦ C and 5% CO2 . REKs were rinsed three times in PBS before adding
room temperature Opti-MEM (ThermoFisher, Cat# 31985070) and transferring to a live cell
imaging apparatus maintained at 37 ◦ C. Once enzymatically modified, calcein red-orange
is trapped inside live cells and can only pass to an adjoining cell via functional gap junction
channels. Randomly selected single cells within small cell clusters were imaged prior
to bleaching on a Zeiss LSM 800 confocal Airyscan microscope equipped with a 63× oil
immersion objective lens. A 561-nm argon laser was used to photobleached cells to ~20%
of their initial fluorescence intensity. Fluorescence recovery, due to the passage of calcein
red-orange from contacting cells, was imaged at 1 s intervals for 2 min and quantified using
the Time Series Analyzer v3 (https://imagej.nih.gov/ij/plugins/time-series.html, accessed
on 22 September 2021) plugin for ImageJ (U. S. National Institutes of Health, Bethesda,
MD, USA, https://imagej.nih.gov/ij/, accessed on 22 September 2021). Fluorescence
recovery as defined by the area under the curve (AUC) was calculated and normalized to
the fluorescence recovery of wildtype Cx43 at 120 s. Data were analyzed using a one-way
ANOVA with Tukey’s post-hoc test.
2.4. Scrape Load Dye Transfer Assay
Control, Cx43-ablated REKs, and Cx43-ablated REKs engineered to express wildtype
Cx43 or Cx43 variants were grown to confluency in cell culture treated six-well plates
(ThermoFisher, Cat# 140675). Cells were exposed to gap junction permeable Lucifer yellow
(1.5 mg/mL) (457 Da) (MilliporeSigma, Cat# L0259-25MG) and the gap junction impermeable dextran rhodamine B (0.5 mg/mL) (10,000 Da) (ThermoFisher, Cat# D1824) in PBS.
Each well was scraped in three distinct locations using a scalpel blade and incubated for
three minutes at 37 ◦ C and 5% CO2 . Subsequently, the PBS-dye solution was aspirated, and
cells were washed three times with PBS and fixed with 10% neutral-buffered formalin for
15 min at room temperature. Three random images were captured along each scrape line
using a Zeiss LSM 800 confocal Airyscan microscope equipped with a 10× objective. The
distance of Lucifer yellow transfer was measured from the scrape edge using ImageJ, and
data were analyzed using a one-way ANOVA with Dunnett’s multiple comparisons test.
2.5. Dual Whole Cell Patch Clamp
On the day of patch clamp, REKs and Cx43-ablated REKs were trypsinized, plated
onto glass coverslips, and incubated for 2 h at 37 ◦ C and 5% CO2 . Coverslips were
transferred to a recording chamber, washed, and bathed in extracellular solution containing
140 mM NaCl, 2 mM CsCl, 2 mM CaCl2 , 1 mM MgCl2 5 mM HEPES, 4 mM KCl, 5 mM
D-Glucose, and 2 mM pyruvate at pH 7.4. Glass micropipettes were pulled with a PC-100
puller (Narishige, Amityville, NY, USA) and filled with intracellular solution composed
of 130 mM CsCl, 10 mM EGTA, 0.5 mM CaCl2 , 3 mM MgATP, 2 mM Na2 ATP, and 10 mM
HEPES at pH 7.2 [42]. The patch pipette resistance was typically 2–3 MΩ. Isolated cell
pairs were selected for dual whole cell patch clamp, with each of the cells under voltage
clamp at 0 mV. One cell in the pair received seven second duration transjunctional voltage
(Vj ) pulses ranging from ±20 to ±100 mV (at 20 mV increments), while the other cell of the
pair remained at a constant holding potential of 0 mV to record junctional currents (Ij ), as
previously described [42]. Macroscopic junctional conductances (Gj ) were calculated from
the Ij recorded during a ±20 mV Vj pulse (Gj = Ij / Vj ) [43,44].
2.6. Propidium Iodide Dye Uptake Assay
Hemichannel function was assessed by a dye uptake assay, similar to Tong et al.
(2007) [45]. Connexin-deficient HeLa cells were seeded on glass coverslips in six-well plates
at low density, transfected, and incubated for 24 h at 37 ◦ C and 5% CO2 . Growth media
was aspirated, and cells were gently washed twice with divalent cation-free extracellular
solution (DCF-ECS) (140 mM NaCl, 5.4 mM KCl, 2 mM EGTA, 10 mM HEPES, 25 mM
D-glucose, osmolarity 298 mOsm, pH 7.35) and incubated in 1 mL DCF-ECS containing
0.15 mM propidium iodide (PI; 668.4 Da) (ThermoFisher, Cat#P1304MP) for 15 min. The
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incubation solution was then aspirated, and the cells were gently washed three times with
regular extracellular solution (ECS) (140 mM NaCl, 5.4 mM KCl, 1.4 mM MgCl2 , 2 mM
CaCl2 , 10 mM HEPES, 25 mM D-glucose, osmolarity 298 mOsm, pH 7.35). Cells were
subsequently fixed with 4% paraformaldehyde for 20 min at room temperature, nuclei
counterstained with Hoechst 33342, and the coverslips mounted onto glass microscope
slides using Airvol mounting medium. Images were captured on a Zeiss LSM 800 confocal
Airyscan microscope equipped with a 10× objective lens. A third-party investigator,
blinded to the treatment, was used to quantitate the percentage of GFP-positive connexinexpressing cells loaded with PI. Between 30 and 160 cells were counted for each coverslip
in each experimental group.
2.7. Brefeldin A Treatment
To assess the clearing of wildtype and variant gap junction plaques, 24 h after transfection, Cx43-ablated REKs were treated with 2 µg/mL brefeldin A (BFA) (MilliporeSigma,
Cat# B5936) for up to 7 h at 37 ◦ C and 5% CO2 to inhibit anterograde protein transport between the ER and Golgi apparatus. Coverslips were collected at 1- or 2-h intervals and cells
were fixed in ice cold 80% methanol/20% acetone at 4 ◦ C for 10 min and nuclei stained with
Hoechst 33342. Images were captured using a Zeiss LSM800 Airyscan confocal microscope
equipped with a 63× oil immersion objective lens. Between 10 and 90 GFP-positive cell
pairs were assessed at each timepoint, with a total of five biological replicates performed.
A third-party investigator that was blinded to the treatment quantified the number of Cx43
gap junction plaques between GFP-positive cell–cell pairs.
2.8. Cycloheximide Treatment and Western Blot
Cx43-ablated REKs expressing wildtype or variant Cx43 were treated with 10 µg/mL
cycloheximide (CHX; MilliporeSigma, Cat# C7698) for 0, 1, 3, 5, or 7 h at 37 ◦ C and 5%
CO2 to inhibit protein synthesis. At each time point, cell lysates were prepared on ice
using RIPA lysis buffer (150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1%
sodium dodecyl sulphate, 50 mM Tris, pH 8.0) supplemented with 100 mM NaF, 100 mM
NaVO4 , and a complete™ mini protease inhibitor cocktail tablet (MilliporeSigma, Cat#
11836153001). Protein concentrations were subsequently determined using a bicinchoninic
acid assay kit (ThermoFisher, Cat# 23225). Proteins were transferred from a 10% SDS-PAGE
gel onto nitrocellulose membranes using the iBlot® dry-transfer system (ThermoFisher).
Membranes were blocked in 5% skim milk and incubated with rabbit polyclonal antiCx43 antibody (MilliporeSigma, Cat# C6219) (1:5000) and mouse anti-glyceraldehyde-3phosphate dehydrogenase antibody (GAPDH; MilliporeSigma, Cat# MAB374) (1:5000)
at 4 ◦ C overnight. The following day, membranes were washed and labeled with goat
anti-rabbit IgG IRDye 800 (Rockland Immunochemicals, Pottstown, PA, USA, Cat# 611132-002) (1:5000) and goat anti-mouse IgG Alexa Fluor 680 (Life Technologies, Burlington,
ON, Canada, Cat# A21057) (1:5000) for 45 min at room temperature. Protein bands were
visualized and quantified using the Odyssey LiCor infrared imaging system. A total of
three to six replicates were performed. The ratio of Cx43/GAPDH was calculated for each
time point and normalized to 0 h for each treatment. Data were analyzed using a one-way
ANOVA with a Dunnett’s post-hoc test.
3. Results
3.1. Cx43 Is the Major Contributor to GJIC in REKs
We have previously shown that the CRISPR/Cas9 ablation of Cx43 significantly
reduces the ability of REKs to pass dye [40]. Here, we show that Cx43 was undetected in
Cx43 knockout (KO) REKs but was readily observed in gap junctions between wildtype
REKs (Figure 1A, arrows). Dual whole cell patch clamp was used to record Ij for calculation
of junctional coupling conductance (Gj ). Cx43–KO REK cell pairs showed significantly
reduced Gj compared to those of wildtype REKs (p < 0.01) (Figure 1B,C). Notably, Cx43-KO
REKs retained low levels of Gj s, including some Ij s, showing voltage-dependent gating
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3.3. Wildtype Cx43 and Variants Enhance Dye Transfer in Cx43-KO REKs
We next used fluorescence recovery after photobleaching (FRAP) to assess the functional status of gap junctions formed by Cx43 variants. Briefly, single cells in small clusters
of Cx43 or variant expressing cells loaded with a gap junctional permeable dye were
bleached and fluorescence recovery was tracked and quantified. Representative images
showcase calcein red-orange fluorescence in Cx43–KO REKs pre-bleaching, immediately
after photobleaching, and after a two-minute recovery period (Figure 5A). Fluorescence
recovery was plotted as a function of time normalized to the level of fluorescence recovery
of wildtype Cx43 at 120 s (Figure 5B). Quantification of the area under the curve revealed
that re-expression of wildtype Cx43 and all Cx43 variants significantly restored dye transfer in Cx43-KO REKs (p < 0.0001) (Figure 5C). Calcein red-orange, while easily optically
distinguished from the GFP fluorescent tag of Cx43 and variants, is a relatively large dye
(570 Da), which may restrict its passage through Cx43 channels. Thus, we also tested the
ability of Cx43 variants to pass the smaller molecular weight dye, Lucifer yellow (457 Da),
in a scrape load assay where dextran rhodamine B (10,000 Da) was used to demarcate
damaged cells at the scrape edge (Figure 5D). Cx43-KO REKs expressing wildtype Cx43 or
Cx43 variants exhibited a significantly greater degree of Lucifer yellow dye spread than
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control Cx43-KO REKs (p < 0.0001) (Figure 5E). Taken together, these results suggest that
EKVP-associated variants form functional gap junction channels.
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(570 Da), which may restrict its passage through Cx43 channels. Thus, we also tested the
ability of Cx43 variants to pass the smaller molecular weight dye, Lucifer yellow (457 Da),
in a scrape load assay where dextran rhodamine B (10,000 Da) was used to demarcate
damaged cells at the scrape edge (Figure 5D). Cx43-KO REKs expressing wildtype Cx43
or Cx43 variants exhibited a significantly greater degree of Lucifer yellow dye spread than
9 of 16
control Cx43-KO REKs (p < 0.0001) (Figure 5E). Taken together, these results suggest that
EKVP-associated variants form functional gap junction channels.
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images of cells prior to photobleaching, immediately following photobleaching (0 s), and after a 120 s
recovery period. Scale bars = 10 µm. (B) Fluorescence recovery mediated by gap junctional transfer of
dye from adjacent cells was monitored over 120 s and normalized to Cx43 at 120 s. (C) Quantification
of the area under the curve revealed that re-expression of wildtype or Cx43 variants enhanced dye
transfer in Cx43-ablated REKs. (D) Representative images of Cx43–KO REKs expressing GFP-tagged
wildtype or Cx43 variants (green) were scraped-loaded with Lucifer yellow (LY, yellow) and dextran
rhodamine B (DRhoB, red). Scale bars = 50 µm. (E) The distance of LY dye spread from the scrape
edge was significantly increased in keratinocytes expressing wildtype or Cx43 variants compared to
control Cx43-KO REKs. **** p < 0.0001.

3.4. Cx43 Variants Do Not Form Hyperactive Hemichannels
Since augmented hemichannel function has been reported for other EKVP-linked
mutants [23], we wanted to assess if the removal of extracellular divalent cations would
lead to a potential pathological level of variant Cx43 channel opening in culture cells. HeLa
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Figure 6. Cx43 variants do not form hyperactive hemichannels permeable to propidium iodide
Figure 6. Cx43 variants do not form hyperactive hemichannels permeable to propidium iodide (PI).
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3.5. The P283L Variant Persists Longer in Gap Junctions than Wildtype Cx43
3.5. The P283L Variant Persists Longer in Gap Junctions than Wildtype Cx43
Since the EKVP-associated variants occur in a motif of Cx43 that is the binding site for
Since the EKVP-associated variants occur in a motif of Cx43 that is the binding site
several members of the interactome and a domain known to regulate Cx43 internalization
for several members of the interactome and a domain known to regulate Cx43 internaliand degradation (Table 1) [31–38], we next sought to assess the resident time of wildtype
zation and degradation (Table 1) [31–38], we next sought to assess the resident time of
and Cx43 variants within gap junctions at the cell surface. When brefeldin A (BFA) was
wildtype and Cx43 variants within gap junctions at the cell surface. When brefeldin A
used to reversibly block protein secretion at the level of the ER/Golgi apparatus, the
(BFA) was used to reversibly block protein secretion at the level of the ER/Golgi appaclearing of gap junctions composed of wildtype and Cx43 variants was tracked over a
ratus, the clearing of gap junctions composed of wildtype and Cx43 variants was tracked
seven-hour treatment (Figure 7A,B). Gap junctions composed of the P283L and T290N
over a seven-hour treatment (Figure 7A,B). Gap junctions composed of the P283L and
variants had statistically longer residency time at the cell surface after 5 h of BFA treatment
T290N variants had statistically longer residency time at the cell surface after 5 h of BFA
compared to wildtype Cx43, while gap junctions composed of P283L appeared to have a
longer residency, but this was just below statistical significance. This finding suggests that
a combination of the two variants is affecting Cx43 clearing from the cell surface and may
have implication in the EKVP phenotype.
Table 1. Cx43 protein binding motifs near the site of the EKVP associated variants. The proline
residue at position 283 is underlined.
Cx43 Motifs

Binding Protein

References

263 QKYAYFNGCSSPTAPLSPMS282

Hsc70
c-Src/PTEN/Csk
NEDD4
µ2 subunit of AP-2

[31,37]
[31,33–35]
[31,32]
[31,36]

266 AYFNGCSSPTAPLSPMSP283
283 PPGY286
286 YKLV289
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Figure 8. The P283L variant contributes to a slower degradation of Cx43. (A) Illustration of cycloheximide
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(CHX) inhibition of protein synthesis in the context of the Cx43 lifecycle from transcription through
to internalization and degradation. (B) Immunoblots of Cx43–KO REKs expressing GFP-tagged
wildtype or Cx43 variants (green) treated with CHX for 0 to 7 h. GAPDH (red) was used as an
internal control. (C) The Cx43/GAPDH ratio was calculated and normalized to 1. (D) After 3 h of
CHX treatment, the P283L and P283L + T290N variants were found to be significantly higher than
wildtype Cx43. * p < 0.05; ** p < 0.01. Schematic in panel A was created using BioRender.com.

4. Discussion
Keratinocytes differentially express at least eight connexin isoforms that act to create a
dynamic gap junctional network within the epidermis that regulates epidermal homeostasis.
Cx43 is the most abundant connexin in the epidermis, with high levels of expression in
the basal and spinous layers that taper off in the granular layer [3,5,6,14]. It is apparent
that Cx43 plays a pivotal role in the epidermis, as highlighted by a fatal defect in barrier
function in genetically-modified mice harboring a C-terminal truncated mutant of Cx43 [49]
and the association between some Cx43 mutations and skin disorders [17,18,20–22,50–56].
We previously showed that ablation of Cx43 from REKs significantly impairs keratinocyte
differentiation into organotypic epidermis, concomitant with a reduction in gap junctionmediated dye transfer between keratinocytes [40]. In the present study, we found that
electrical coupling between pairs of Cx43-ablated keratinocytes is significantly reduced,
but not abolished, establishing that Cx43 is the major contributor to the overall level of
GJIC in cultured keratinocytes. Since REKs mimic basal keratinocytes in vivo by being
proliferation, migration and differentiation-competent [40,41], we propose that Cx43 is
likely accounting for the majority of GJIC in rat basal keratinocytes in situ.
Currently, four autosomal dominant mutations/variants in the GJA1 gene (encoding
Cx43) have been clinically associated with EKVP [17,18]. The A44V and E227D mutations
have been shown to exhibit augmented hemichannel function, which is likely informing on
the mechanistic root of EKVP in patients harbouring these mutants [23]. The more recently
discovered de novo GJA1 variants (encoding P283L and T290N) have been reported in
only two patients [18], so it remains unclear if one or both of these variants are indeed
causal of EKVP. It is notable that the one patient that harbors both the P283L and T290N
variants has more severe EKVP than the patient that expresses only the P283L variant [18]
raising questions as to whether there is any additive or synergistic relationship between
the genotype and phenotype.
Localization of Cx43 in skin biopsies from EKVP patients raised the possibility that
one or both of these variants were retained within an intracellular compartment [18].
High resolution imaging of the P283L and T290N variants expressed in keratinocytes
revealed that they assembled into prototypical gap junctions in the presence or absence
of endogenous Cx43. Thus, not unlike the clinical report describing the A44V and E227D
mutants as potentially trafficking defective [17], being later shown to assemble into gap
junctions when overexpressed in HeLa cells [23], we conclude that both P283L and T290N
variants can readily traffic from the ER though the Golgi apparatus to form gap junctions
at the cell surface in tissue-relevant REKs. Our initial studies using a dual whole cell patch
clamp to determine if the variants formed functional gap junctions in REKs resulted in
cell pairs that had junctional conductances that exceeded 50 nS, masking the distinction
between excellent gap junction coupling and cytoplasmic bridging that may exist between
REKs that were undergoing cell division (data not shown). However, FRAP and scrape
loading dye transfer studies engaging two distinctly different dyes (calcein red-orange
and Lucifer yellow) consistently revealed that both variants exhibited GJIC levels that
were comparable with wildtype Cx43. The fact that the P283L and T290N variants formed
functional gap junctions aligns well with the previous finding that the A44V and E227D
EKVP-associated mutants formed functional gap junctions with similar unitary channel
conductance and voltage gating properties as reported for wildtype Cx43 [23]. However,
A44V and E227D hemichannels adopted open configurations more frequently and for a
longer duration than wildtype Cx43 hemichannels [23]. In our studies, the P283L or T290N

Int. J. Mol. Sci. 2022, 23, 486

13 of 16

variants did not acquire a detectable constitutively open or leaky hemichannel state. This
is consistent with variant expressing cells lacking any evidence of necrosis or apoptosis
in the event that leaky hemichannels were releasing vital members of the metabolome
necessary for cell survival. We cannot rule out that more subtle changes are occurring
at the hemichannel level, but this awaits an electrophysiological assessment in a defined
culture system where channels formed from other integral membrane proteins, such as
endogenous hemichannels, can systematically be eliminated.
Cx43 undergoes continuous and rapid turnover with a half-life of 1–3 h [48,57–59],
and changes in connexin half-life kinetics may have linkages to the onset of developmental
abnormalities and disease [38,60–62]. It is also known that the C-terminal domain of Cx43
has a large interactome that includes binding sequences for NEDD4, an E3-ubiquitin ligase,
and AP-2, that are likely all involved with Cx43 internalization [31]. Interestingly, the
P283L and T290N variants reside in or near the PPxY motif important in regulating Cx43
sorting and internalization [31,36]. In the present study, we showed that keratinocytes
co-expressing both Cx43 variants displayed significantly delayed kinetics of gap junction
removal, suggesting that they reside in a motif that is important for gap junction clearing
from the cell surface. It is likely that the P283L variant plays a larger role in delaying Cx43
gap junction internalization, as it was previously found to have modestly higher steadystate levels than wildtype Cx43 when transiently expressed in SKHep1 cells [36]. Since
internalization of variant-containing gap junctions was delayed, we predicted that one or
both variants might lead to a delay in degradation in the presence of CHX. This turned out
to be the case for the P283L variant, but not the T290N variant. This finding is generally in
keeping with a recent study in culture cells and zebrafish where a ∆256–289 mutant caused
dysregulated Cx43 gap junction endocytosis resulting in a longer Cx43 protein half-life,
elevated levels of Cx43, more numerous and larger gap junction plaques, and increased
GJIC that coincided with severe cardiovascular defects [38]. Thus, we deduced that the
P283L variant has a significant impact on the fate of Cx43. The T290N variant appears to
further augment Cx43 internalization and its residency time on the cell surface when found
in combination with the P283L variant.
We can only speculate on how prolonged Cx43 residency within functional gap junctions might disrupt the homeostasis of the epidermis. The fact that delayed Cx43 removal
leads to cardiovascular defects in zebrafish suggests that potentially too much GJIC can
lead to a pathology [38]. In the skin, dysregulated control of Cx43 turnover may change
the delicate balance between keratinocyte proliferation and differentiation. For example,
extended Cx43-based cell coupling may allow basal keratinocytes to remain in a prolonged
proliferative state, delaying keratinocyte differentiation, thereby giving rise to the hyperkeratosis seen in EKVP. That said, it remains unclear how these Cx43 variants might be
linked to erythema. The short half-life of Cx43 is thought to allow cells to quickly alter
the extent of GJIC, thus any delay in this process could lead to a dysregulated response to
pathogenic stimuli, leading to inflammation and erythema.
Caution needs to be exercised in concluding that the observed modest delay in Cx43
gap junction clearing and/or degradation found in our study causes EKVP observed in
patients harboring the P283L or P283L + T290N variants. Other mechanisms that need to
be considered include the possibility that Cx43 variants gain other functions, such as the
capacity to interact with any of the other half-dozen or more connexin isoforms found in
the epidermis [3]. However, even if that was the case, since the variants are functional it
is not clear how that would lead to a pathology. Since whole exome sequencing does not
appear to have been performed on these EKVP patients, other genetic causes of disease
need to be considered and ruled out, as a number of genes unrelated to connexins have
been linked to the heterogeneity of EKVP diseases [26–30]. Nevertheless, the variant-linked
prolonged persistence of Cx43 gap junctions and modest delay in degradation highlights
yet another possible mechanism underpinning EKVP.
EKVP pathogenesis is complex, involving at least three connexin isoforms (Cx30.3,
Cx31, and Cx43) that are temporally and spatially expressed in the epidermis [3]. Similar to
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congenital cataracts linked to Cx50 and Cx46 [63], EKVP represents another disease linked
to multiple connexins, raising questions as to what mechanistic feature of each connexin
variant leads to the same clinical disease. Already, two mechanisms have been proposed
that include augmented hemichannel function [23,24], defective trafficking [64,65], and
now, possible alterations in gap junction fate and degradation. As there is a lack of effective
treatments for EKVP, it is critical to characterize all known connexin variants associated with
EKVP to help shape the development and deployment of strategically targeted treatments
for this disorder.
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